Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Newly Upgraded Software Suite Expands Microscopy Applications

By LabMedica International staff writers
Posted on 06 Oct 2014
A newly upgraded software suite improves image acquisition, processing, and analysis for most applications including widefield, confocal, and super-resolution microscopy.

Leica Microsystems (Wetzlar, Germany) has launched the easy-to-use Leica Application Suite X (LAS X) imaging software for biotech and life sciences research laboratories. More...
LAS X is the successor to the popular LAS AF software package.

LAS X begins with the LAS X Core unit that features microscope control, full image viewer capability, diverse processing and quantification tools, movie export, the ability to recall imaging parameters and much more. Several application packages are available that enhance the versatility of the core unit. These include modules for specific tasks such as high content screening, FRET (Fluorescence Resonance Energy Transfer), FRAP (Fluorescence Recovery after Photobleaching), multidimensional analysis, and colocalization measurements.

For live cell applications, hardware-based Adaptive Focus Control (AFC) and software-based autofocus are integrated in LAS X. Experimental conditions such as temperature, carbon dioxide and oxygen levels are documented and controlled with the Environmental Control module. For long-term time-lapse and screening experiments, the software-controlled microdispenser compensates for evaporation.

LAS X enables easy multichannel analysis of even complicated fluorescent experiments. A separate analysis channel can be created for each fluorescent marker and assigned an individual workflow. Analysis of all aspects of the sample can then be run at the same time. Combined analyses from separate channels generate specific object data. For example, one analysis channel can count healthy cells on a stained color image while a second analysis channel counts abnormal cells.

Markus Schechter, product manager at Leica Microsystems, said, "In developing the new imaging software platform LAS X, we have focused on the user-friendliness of the software. We have taken common workflows most users know and follow into account and translated them into software and this way continued the workflow-based approach of the predecessor LAS AF."

Related Links:
Leica Microsystems



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.